TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,831,401 | +30.8% | 183,025 | +32.8% | 0.00% | 0.0% |
| Q2 2023 | $2,164,538 | +672.7% | 137,781 | +710.5% | 0.00% | – |
| Q1 2023 | $280,144 | +35.5% | 16,999 | +28.3% | 0.00% | – |
| Q4 2022 | $206,762 | +16.8% | 13,254 | -2.8% | 0.00% | – |
| Q3 2022 | $177,000 | +24.6% | 13,629 | +35.5% | 0.00% | – |
| Q2 2022 | $142,000 | -74.4% | 10,057 | -74.0% | 0.00% | – |
| Q1 2022 | $554,000 | -1.9% | 38,716 | -6.6% | 0.00% | – |
| Q4 2021 | $565,000 | -59.1% | 41,456 | -50.9% | 0.00% | -100.0% |
| Q3 2021 | $1,383,000 | -68.3% | 84,437 | -67.4% | 0.00% | -50.0% |
| Q2 2021 | $4,358,000 | -36.4% | 258,962 | -31.0% | 0.00% | -33.3% |
| Q1 2021 | $6,857,000 | +16.8% | 375,534 | +16.4% | 0.00% | +50.0% |
| Q4 2020 | $5,873,000 | -10.3% | 322,697 | -12.0% | 0.00% | -33.3% |
| Q3 2020 | $6,546,000 | -11.5% | 366,895 | -13.5% | 0.00% | -25.0% |
| Q2 2020 | $7,398,000 | +1.0% | 424,150 | -12.1% | 0.00% | -20.0% |
| Q1 2020 | $7,322,000 | -12.1% | 482,357 | +14.3% | 0.01% | +25.0% |
| Q4 2019 | $8,331,000 | -17.0% | 422,181 | -27.9% | 0.00% | -20.0% |
| Q3 2019 | $10,034,000 | -6.6% | 585,378 | -3.5% | 0.01% | -16.7% |
| Q2 2019 | $10,740,000 | +17.8% | 606,830 | +35.6% | 0.01% | +20.0% |
| Q1 2019 | $9,116,000 | – | 447,513 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |